$TRON There are a couple of interesting pointers tilting in

New Post Public Reply Private Reply Replies (0) Message Board
Mysterium
924
$TRON There are a couple of interesting pointers tilting in the direction of future acquisitions, aside from those assertions by CEO Morentin in press releases.

For those just getting eyes on this, if you go through the DD packets and/or press releases, you will see the mention of "a series of acquisitions" or "first in a series of acquisitions". Let's pick apart some additional soundbites, and we'll throw a clip of two from CEO Morentin in along the way.


First, let's pick apart the wording in the Flagship confirmation letter.

https://twitter.com/rvom110/status/1057633512138846208


"As you know, Flagship is engaged in healthcare and nursing facilities and we believe our joint combined efforts will solidify Toron and InMed as a force in the Southeastern United States healthcare market.

Thank you again for this opportunity and we look forward to this continued partnership."



Think about what is being said here. If InMed was already a "force" in the Southeastern United States healthcare market, then what would change just by having Toron acquire it? Nothing - unless Toron was a vehicle for expansion and growth. And why would Flagship mention a continued partnership once the InMed deal was sealed and done with? They are a financier, so a continued partnership would mean that they must continue bringing something to the table in the future, which would obviously mean capital. That capital would not be to pay for the same acquisition deal twice, so putting one logical foot in front of the other, there is strength in the likelihood of more to come.


That letter was sent out on October 25, 2018. Now lets look at the press release on October 31, 2018.


“We are pleased to announce that Toron has accepted and executed a Letter of Intent for a $10 million working capital facility from a privately held finance company specializing in financing healthcare providers in the United States. With this working capital facility in place, we can implement our strategic plans for operations and we shall be poised to explore additional
acquisition opportunities to add to our base of operations"



Okay, so here we have an unmentioned finance company who specializes in financing healthcare providers. Pretty strong odds it is Flagship. That cannot be stated with certainty, but it is the best guess at the current time.

Going back a bit, when Flagship offered the LOI for funding back in 2017, it was specifically for InMed. With $10.9M already out the door on InMed, why would they, or any other potential entity, finance $10M more without knowing what it was going towards and how they would get it back with an additional return? They are not going to just hand over the money for the thought of any garden variety of potential acquisitions. A financier is going to want to see some paperwork on the target or targets, even if it is a narrowing down from three strong prospects, so as to land the strongest deal among them in the end. Targeted entities, numbers, operations, and a game plan are going to be needed to play ball.

And as far as becoming a force in the Southeastern United States healthcare market, "adding to our base of operations" would help with that significantly, and would add to the declaration of a "continued partnership".


Now, on November 14, 2018, CEO Jarry of InMed was quoted in Toron's press release. Consider the following line:

"We are pleased to become part of the Toron family and towards building a stronger and expanded healthcare network.”

So now we have CEO Jarry of InMed speaking of an "expanded healthcare network", CEO Shah of Flagship voicing a "continued partnership", and foreseeing InMed and Toron become" a force in the Southeastern United States healthcare market", and CEO Morentin of Toron making public mention of an additional executed LOI for a second tranche of $10M in funding to "explore additional acquisition opportunities and add to our base of operations". That statement sounded like it was in the plural format, not just "an additional acquisition opportunity".


Flagship seems to be the go-to financier, InMed seems to be the base from which the "force" will be expanded from, with CEO Jarry likely working on the growth and revision alongside Brad Eisemann, and Rene seems to be captaining the exploration process from whose lens it will be decided which targets will be worth pursuing, and how to go about executing the deals and structuring them.

InMed is not all there is to the show. This is just the base, not the expansion. If it is not already a force, then to become a force, it must expand in scope, locations and revenue. That lines up with CEO Jarry's wording about "building a stronger and expanded healthcare network".

I sense there is a lot more on the way. There is a reason the board of directors is expanding. Toron is more than just the original InMed deal. Toron is a force.

ALL THINGS MOBILE ANALYTIC INC. (ATMH) Stock Research Links

ATMH Board Company Profile Buy Rating Time & Sales News Filings Financials
Do your own DD. Assume everyone here is either an amateur trader/investor or a paid interest such as a compensated pumper/basher. My posts are strictly for entertainment purposes. I am not on Wall St., do not work for a group, and only get paid when my personal investments materialize. I am only responsible for my own gains and losses; no one is to blame for my mistakes or for any advice taken from postings; likewise, I am not to blame for any advice you take of mine, regardless of gains or losses from doing so. Good luck to all; may you live long and prosper greatly.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 42

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Concierto's Azure Push Puts Sovereignty on Display

Updated Category News Views 78

Sovereignty has become the corporate cloud world's favorite hard-edged word. Concierto is taking that word straight onto the Microsoft Ignite 2026 floor, and frankly, it is a sensible place to make the case. The company, part of Trianz, will appear as a Gamechanger Sponsor from November 17 through 20 at San Francisco's Moscone Center, showing its platform at Booth #5435....

Continue Reading
Thoughts Unleashed Arrives With a Personal American Voice

Updated Category News Views 114

A lifetime of observation finally gets its own page Forty is an unusual age to begin writing poetry, which is exactly why Joyce Ann Grooms McGeehan's debut has a little more texture than the usual polished promise of inspiration. Thoughts Unleashed by an Independent, American Woman comes from someone who spent decades teaching French, English, and ESL, then retired to a...

Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves

Updated Category News Views 110

Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...

Continue Reading
ZTO's Pricing Muscle Shows Up in Third-Quarter Results

Updated Category News Views 136

Ten billion parcels can hide plenty of ugly economics, but ZTO's third quarter does not look like a volume-at-any-cost stunt. The company moved 10.241 billion parcels, up 7.0% from a year earlier, and says that outpaced the industry by 4.1 percentage points. More importantly, revenue climbed 21.0% to RMB14.36 billion while adjusted net income reached RMB2.57 billion. That...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 76

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 68

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 80

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 160

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 114

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Update for Investors in Metagenomi Class Action

Updated Category News Views 103

Key Deadline for Metagenomi Investors As investors in Metagenomi, Inc. keep a close watch, an important deadline is approaching. The time to file a lead plaintiff motion in the class action lawsuit is set for November 25, 2024. This action is vital for those who purchased or acquired Metagenomi securities, specifically those linked to the company’s latest initial public...

Continue Reading
Structure Therapeutics Engages with Investors at Key Conferences

Updated Category News Views 78

Structure Therapeutics Engages with Investors at Key Conferences Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company, is gearing up to participate in important investor conferences this September. The company is dedicated to developing innovative oral small molecule therapeutics aimed at treating metabolic and cardiopulmonary...

Continue Reading
OmaSp Reports Solid Financial Performance with Growth Prospects

Updated Category News Views 156

OmaSp's Strong Financial Performance and Future Outlook OMA SAVINGS BANK PLC has recently released its financial statements for the year ending December 31, 2024, showing promising results and projections for continued growth. Known as OmaSp, the bank reported a noteworthy fourth quarter, aligning with the expectations set forth at the beginning of the year, and a solid...

Continue Reading
Unveiling the Reagan National Economic Forum for Future Growth

Updated Category News Views 485

Reagan National Economic Forum Set to Inspire Economic Solutions The Ronald Reagan Presidential Foundation and Institute is gearing up for a transformative inaugural economic summit with leading figures from the business and economic policy landscapes to take place in late May 2025. About the Forum’s Objectives The Reagan National Economic Forum (RNEF) aims to provide a...

Continue Reading
Experience the Vibrant Latin Business Networking Event of 2025

Updated Category News Views 279

Celebrating the Latino Business Community Prepare yourself for an unforgettable networking event dedicated to the Latino business community, brought to you by Latin Biz Today and Mercy University. The Spectrum of Success event promises a night filled with excitement, learning, and cultural experiences that will leave a lasting impression on everyone involved. A Night of...

Continue Reading